Metabolon introduces ‘groundbreaking’ bioinformatics platform

Metabolon introduces ‘groundbreaking’ bioinformatics platform

Related tags Data Data collection Data management Artificial intelligence data platform

Metabolon, Inc., a prominent figure in metabolomics solutions, has launched a seminal integrated bioinformatics platform, aiming to redefine metabolomics analysis in life sciences research.

The announcement was made at Biomarkers UK, and it was used as an opportunity to showcase Metabolon's latest platform designed, the company says, to propel the landscape of metabolomics analysis.

Drawing on more than two decades of industry-leading experience, Metabolon says it now boasts an established database of more than 5,400 biologically relevant metabolites, the platform seamlessly integrates a comprehensive suite of tools and features.

Among these features is pathway analysis, enabling researchers to explore the intricate workings of biological processes and uncover insights into disease mechanisms and therapeutic targets.

Biomarker Lenses, a feature unique to Metabolon, provides advanced analytical filters to enhance the exploration of metabolomic data by focusing on specific pathways and diseases.

Interpretation of complex data sets

Principle Component Analysis (PCA) aids researchers in reducing complex datasets and visualizing research results effectively. Partial Least Squares–Discriminant Analysis (PLS-DA) facilitates the interpretation of complex datasets, allowing for the identification of distinctive biomarkers driving group separation.

Researchers can now organize metabolites and samples into meaningful groups based on metabolite features using the clustering feature of the database, the company said. Another feature volcano plots assist in identifying statistically significant changes in large datasets, revealing biologically relevant metabolites.

David Broadhurst, professor of biosystems data science at Edith Cowan University, Australia, said: “I love working with Metabolon data. It is an incredibly forward-thinking company, actively engaging with the evolving interdisciplinary challenges of robust clinical metabolomics.

“Metabolon has developed a solid, scalable solution to the non-trivial problem of metabolomics biochemical interpretation, specifically tailored to their world-leading data acquisition platform. Leveraging decades of experience in data curation, Metabolon provides intuitive visualization tools for pathway analysis and disease association, adding even more value to an already outstanding product.”

Alleviating the manual burden of data organization 

The company says that in an era where precision medicine, advanced analytics, and big data reign supreme, its platform alleviates the manual burden of data organization and preparation. The platform pre-populates client data, expediting discovery with publication-ready charts, plots, data tables, and insights.

Ray Moran, senior director of bioinformatics at Metabolon, said: Metabolon is thrilled to unveil this groundbreaking bioinformatics platform, marking a significant leap forward in metabolomics research.

“By combining our extensive industry experience with cutting-edge technology, we are empowering researchers to navigate complex data effortlessly and accelerate discoveries in the life sciences.” 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Related suppliers

Follow us


View more